TrademarkDir
TOZARIDE
LIVE

Serial Number

87691768

Owner

Andarix Pharmaceuticals, Inc.

First Use Date

Feb 1, 2016

Filing Date

Nov 20, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TOZARIDE Trademark

Serial Number: 87691768 • Registration: 5650970

TOZARIDE is a trademark filed by Andarix Pharmaceuticals, Inc. on November 20, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Andarix Pharmaceuticals, Inc.

141 Powderhouse Blvd
Somerville, MA 02144

Entity Type: 03

Trademark Details

Filing Date

November 20, 2017

Registration Date

January 8, 2019

First Use Anywhere

February 1, 2016

First Use in Commerce

September 1, 2016

Published for Opposition

April 17, 2018

Goods & Services

Peptide-based pharmaceutical preparations for the treatment of lung cancer

Filing History

TEAS SECTION 8 RECEIVED
Jan 2, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 8, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 8, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 7, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 6, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 3, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 3, 2018 AITU
USE AMENDMENT FILED
Nov 16, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 16, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 12, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2018 NONP
ASSIGNED TO LIE
Mar 15, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 5, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 5, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 5, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 5, 2018 CNEA
ASSIGNED TO EXAMINER
Mar 5, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2017 NWOS

Related Trademarks